Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market ...

The device has obtained breakthrough device designation and is supported by results from the SELUTION4ISR trial.

The newly approved device from Cordis provides therapy over an extended period of time without leaving a permanent implant ...

FastWave Medical, which is developing next-generation intravascular lithotripsy (IVL) technology, today announced positive interim results from the first-in-human (FIH) feasibility study of its Sola™ ...

DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market was valued at ...

Rival to the Agent DCB had been shown noninferior to DES ...

For the small proportion of TAVR patients at high risk of coronary obstruction, a new registry study confirms that preventive stent implantation across the coronary ostia is safe, with good survival ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

Stents, which were introduced in the U.S. in 1994, are tiny mesh tubes that are inserted at the site of a blockage in a coronary artery that has been opened during balloon angioplasty. The procedure ...

Physician researchers suspect that some cases of coronary artery spasm go unrecognized and are incorrectly treated with stents. The good news – there could be a simple fix to eliminate these ...